RESUMO
Because of increased attention to the issue of trustworthiness of clinical practice guidelines, it may be that both transparency and management of industry associations of guideline development groups (GDGs) have improved. The purpose of the present study was to assess a) the disclosure requirements of GDGs in a cross-section of guidelines for major depression; and, b) the extent and type of conflicts of panel members. Treatment guidelines for major depression were identified and searched for conflict of interest policies and disclosure statements. Multi-modal screens for undeclared conflicts were also conducted. Fourteen guidelines with a total of 172 panel members were included in the analysis. Eleven of the 14 guidelines (78%) had a stated conflict of interest policy or disclosure statement, although the policies varied widely. Most (57%) of the guidelines were developed by panels that had members with industry financial ties to drug companies that manufacture antidepressant medication. However, only a minority of total panel members (18%) had such conflicts of interest. Drug company speakers bureau participation was the most common type of conflict. Although some progress has been made, organizations that develop guidelines should continue to work toward greater transparency and minimization of financial conflicts of interest.
Assuntos
Antidepressivos/uso terapêutico , Pesquisa Biomédica/normas , Conflito de Interesses , Transtorno Depressivo Maior/tratamento farmacológico , Indústria Farmacêutica/organização & administração , Guias como Assunto/normas , Antidepressivos/administração & dosagem , Antidepressivos/efeitos adversos , Pesquisa Biomédica/ética , Ensaios Clínicos como Assunto/ética , Ensaios Clínicos como Assunto/normas , Estudos Transversais , Revelação , Indústria Farmacêutica/normas , Humanos , PolíticasRESUMO
OBJECTIVE: We sought to characterize diagnostic and treatment factors associated with receiving a prescription for benzodiazepines at discharge from a psychiatric inpatient unit. We hypothesized that engaging in individual behavioral interventions while on the unit would decrease the likelihood of receiving a benzodiazepine prescription at discharge. METHOD: This is an observational study utilizing medical chart review (n=1007) over 37 months (2008-2011). Descriptive statistics characterized patient demographics and diagnostic/prescription frequency. Multivariate regression was used to assess factors associated with receiving a benzodiazepine prescription at discharge. RESULTS: The sample was 61% female with mean age=40.5 (S.D.=13.6). Most frequent diagnoses were depression (54.7%) and bipolar disorder (18.6%). Thirty-eight percent of participants engaged in an individual behavioral intervention. Benzodiazepines were prescribed in 36% of discharges. Contrary to our hypothesis, individual behavioral interventions did not influence discharge benzodiazepine prescriptions. However, several other factors did, including having a substance use disorder [odds ratio (OR)=0.40]. Male sex (OR=0.56), Black race (OR=0.40) and age (OR=1.03) were nonclinical factors with strong prescribing influence. CONCLUSION: Benzodiazepines are frequently prescribed at discharge. Our results indicate strong racial and sex biases when prescribing benzodiazepines, even after controlling for diagnosis.
Assuntos
Benzodiazepinas/uso terapêutico , Transtornos Mentais/tratamento farmacológico , Pessoas Mentalmente Doentes , Alta do Paciente , Padrões de Prática Médica/estatística & dados numéricos , Adulto , Ansiedade/tratamento farmacológico , Demografia , Feminino , Humanos , Masculino , Auditoria Médica , Pessoa de Meia-Idade , Análise Multivariada , Alta do Paciente/estatística & dados numéricosRESUMO
OBJECTIVE: Spinal stenosis has been proposed as a previously unrecognized risk factor for neurologic complications after neuraxial techniques. CASE REPORT: We report progression of neurologic symptoms after spinal anesthesia in 2 patients with preexisting spinal stenosis, characterized preoperatively solely by nonradicular back pain. One patient had complete resolution of his proximal lower-extremity weakness/numbness within 48 hours. In the second patient, the pain became severe and disabling, requiring surgical decompression. CONCLUSIONS: We conclude that, until the relative contribution of patient and surgical (eg, positioning, retractors, hypotension) factors is known, the decision to perform neuraxial blockade in patients with severe symptoms of neuroclaudication or recently progressive symptomatic spinal stenosis should be made cautiously. Avoidance of spinal anesthesia is suggested for any procedure with prolonged lordotic positioning or any position that might cause a compromise of the spinal canal because subarachnoid block may contribute to any deterioration suffered by the patient.
Assuntos
Raquianestesia/efeitos adversos , Doenças do Sistema Nervoso/diagnóstico , Doenças do Sistema Nervoso/etiologia , Estenose Espinal/cirurgia , Descompressão Cirúrgica/efeitos adversos , Humanos , Masculino , Pessoa de Meia-Idade , Estenose Espinal/diagnósticoAssuntos
Comércio , Medicina Baseada em Evidências/normas , Assistência Centrada no Paciente/normas , Guias de Prática Clínica como Assunto/normas , Transtorno Depressivo/diagnóstico , Transtorno Depressivo/terapia , Competição Econômica , Medicina Baseada em Evidências/economia , Fidelidade a Diretrizes , Humanos , Padrões de Prática Médica/economia , Estados UnidosRESUMO
BACKGROUND: Cigarette smoking and secondhand smoke exposure (SHS) increase the risk of perioperative complications. Traditionally, anesthesiologists have limited involvement in tobacco control. OBJECTIVE: To develop and disseminate an educational curriculum that educates pediatric anesthesia fellows in tobacco control. METHODS: After IRB approval, an online survey was disseminated to pediatric anesthesiology fellowship directors. RESULTS: Thirty-one surveys were completed. Most report that they ask pediatric patients about tobacco use. A majority advise their patients who smoke about the health effects of smoking, but only 40% advise children to quit, and the majority never provide educational materials to assist in smoking cessation. Half reported that they sometimes or always ask about SHS. Approximately one-third never advise about the ill effects of SHS, nearly half never advise parents to stop smoking, and the majority never provide educational material about quitting to parents. Two-thirds felt that it is their responsibility to advise pediatric patients not to smoke, but less than half felt the same sense of responsibility about advising parents not to smoke. Approximately two-thirds believe that fellowship programs should provide education about the effects of smoking in the perioperative period and the effects of SHS exposure, but few programs do. Almost all would implement a free teaching module about SHS exposure and tobacco control as part of fellowship education. CONCLUSIONS: Many pediatric anesthesiology fellowship directors agree that exposure to cigarette smoke adversely impacts patients in the perioperative period, but few participate in tobacco control, and issues germane to tobacco control are not consistently addressed.